Resonance Specialties Limited (BOM:524218)

India flag India · Delayed Price · Currency is INR
93.65
-3.95 (-4.05%)
At close: Mar 9, 2026
6.00%
Market Cap 1.08B
Revenue (ttm) 899.72M
Net Income (ttm) 88.58M
Shares Out 11.54M
EPS (ttm) 7.71
PE Ratio 12.15
Forward PE n/a
Dividend 1.00 (1.02%)
Ex-Dividend Date n/a
Volume 4,563
Average Volume 5,278
Open 95.99
Previous Close 97.60
Day's Range 90.00 - 95.99
52-Week Range 65.00 - 124.50
Beta -0.19
RSI 41.77
Earnings Date May 19, 2026

About Resonance Specialties

Resonance Specialties Limited engages in the manufacture and marketing of specialty chemicals in India and internationally. It offers pyridine, a chemical used in manufacturing agrochemicals, pharmaceuticals and bulk drugs, dyes, rubber chemicals, etc.; cyanopyridines that are applied in manufacturing of niacinamide; and picolines, including alpha, beta, and gamma picolines used in manufacturing vinyl latex rubber, vitamin B3, and anti-tuberculosis drugs. The company also provides nutritional drug products, such as zinc and chromium picolinate,... [Read more]

Industry Medicinal Chemicals and Botanical Products
Founded 1989
Employees 66
Stock Exchange Bombay Stock Exchange
Ticker Symbol 524218
Full Company Profile

Financial Performance

In fiscal year 2025, Resonance Specialties's revenue was 778.07 million, an increase of 40.70% compared to the previous year's 553.01 million. Earnings were 65.66 million, an increase of 121.20%.

Financial Statements

News

There is no news available yet.